Manhattan Bridge Capital, Inc (LOAN) · Oct 9, 2026 · Other events
Buyback expanded — 250,000 shares authorized vs 100,000; 12-month extension
Manhattan Bridge Capital’s buyback authorization rises from 100,000 to 250,000 shares, but the company makes no commitment to purchase them.
Manhattan Bridge Capital is a small hard-money lender focused on short-term, first-mortgage-backed real-estate loans, with loan growth and profitability constrained by available funding and market conditions. The board materially enlarges the potential buyback. The authorization increases from 100,000 shares to 250,000 and runs for another 12 months.
| Buyback terms | Prior program | New program |
|---|---|---|
| Shares authorized | 100,000 | 250,000 |
| Term | Existing authorization | Additional 12 months |
| Purchase obligation | None | None |
The signal is positive but limited. Relative to the standing situation, this gives management more capacity to return capital and potentially reduce the share count; however, the filing explicitly says purchases may occur from time to time and that the program does not obligate the company to buy any shares. 〔0〕 The increase is therefore an authorization, not evidence that cash has already been deployed.
This is an incremental change, not a new strategy. Manhattan Bridge had already authorized a 100,000-share repurchase program in November 2025, so the market already knew buybacks were part of its capital-allocation toolkit; the new information is the larger ceiling and extended window. Bottom line: The filing modestly strengthens the capital-return story, but its business impact is limited until the company actually repurchases shares.qar
Next quarterly results, expected late October 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!